Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

GLPGGLPG
Showing 6 of 12 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in LAKEFRONT BIOTHERAPEUTICS NV

Yes. Two Sigma holds 81,749 shares of GLPG (Lakefront Biotherapeutics), worth $2.5M, as of its Q2 2026 13F filing. It increased the position from 25,860 shares in Q1 2026. Two Sigma has held GLPG since Q1 2025, across 6 quarterly 13F filings.

Current Value

$2.5M

Current Shares

81,749

Total Value Change

+$1.2M

Total Shares Change

+32,588

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
81,749
+216.1%
$2.5M0.0%$27.73
42
2026-Q1
Increased
25,860
+58.1%
$775,8000.0%$33.05
35
2025-Q4
Decreased
16,360
-27.2%
$534,9720.0%$32.61
0
2025-Q3
Increased
22,459
+3.7%
$777,9800.0%$34.43
26
2025-Q2
Decreased
21,659
-55.9%
$606,2350.0%$27.98
0
2025-Q1
New
49,161
-
$1.2M0.0%$25.46
35

Other major holders of GLPG: SANDS CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used